Literature DB >> 7576035

Prior infection by respiratory syncytial virus or parainfluenza viruses augments virus-specific IgG responses induced by the measles/mumps/rubella vaccine.

B Ziola1, B Karvonen, J Stewart.   

Abstract

We found previously that immunizing cyclophosphamide-treated mice with one Paramyxoviridae virus mixed with dimethyl dioctadecyl ammonium bromide induces T cells which apparently also recognize other Paramyxoviridae viruses. This finding and the fact that respiratory syncytial virus (RSV) and parainfluenza viruses (PIVs) infect children early in life led us to ask if prior RSV or PIV infections influence the antibody response to measles and mumps vaccine viruses. Detection of virus-specific IgG in serum specimens collected randomly or at defined times after measles/mumps/rubella (MMR) vaccination was done with solid-phase enzyme immunoassays. The antibody-binding data obtained were converted to serum antibody titers by an immunoassay curve-fitting computer program. Prior infection by RSV and PIVs correlated with an augmented IgG response not only to measles and mumps virus, but also to rubella virus. Furthermore, the augmentation was greater for responders below the median response. These data show that common early childhood viral infections can influence immunity induced by the MMR vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7576035     DOI: 10.1089/vim.1994.7.205

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  2 in total

1.  Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.

Authors:  Signe Sørup; Christine Stabell Benn; Lone Graff Stensballe; Peter Aaby; Henrik Ravn
Journal:  Vaccine       Date:  2014-11-01       Impact factor: 3.641

2.  Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.

Authors:  Lien Anh Ha Do; Naranzul Tsedenbal; Claire von Mollendorf; Tuya Mungun; Darmaa Bardach; Kim Mulholland
Journal:  J Infect Dis       Date:  2021-10-13       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.